日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer

纳武单抗和二甲双胍治疗难治性微卫星稳定性转移性结直肠癌患者的 II 期临床试验

Mehmet Akce, Batoul Farran, Jeffrey M Switchenko, Manali Rupji, Sandra Kang, Lana Khalil, Amanda Ruggieri-Joyce, Brian Olson, Walid L Shaib, Christina Wu, Olatunji B Alese, Maria Diab, Gregory B Lesinski, Bassel F El-Rayes0

FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review

FOLFIRINOX方案或吉西他滨方案化疗治疗临界可切除和局部晚期胰腺癌:一项多中心、患者水平的荟萃分析和系统评价

Eshmuminov, Dilmurodjon; Aminjonov, Botirjon; Palm, Russell F; Malleo, Giuseppe; Schmocker, Ryan K; Abdallah, Raëf; Yoo, Changhoon; Shaib, Walid L; Schneider, Marcel André; Rangelova, Elena; Choi, Yoo Jin; Kim, Hongbeom; Rose, J Bart; Patel, Sameer; Wilson, Gregory C; Maloney, Sarah; Timmermann, Lea; Sahora, Klaus; Rössler, Fabian; Lopez-Lopez, Víctor; Boyer, Emanuel; Maggino, Laura; Malinka, Thomas; Park, Jeong Youp; Katz, Matthew H G; Prakash, Laura; Ahmad, Syed A; Helton, Scott; Jang, Jin-Young; Hoffe, Sarah E; Salvia, Roberto; Taieb, Julien; He, Jin; Clavien, Pierre-Alain; Held, Ulrike; Lehmann, Kuno

A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01

一项针对既往未接受治疗的晚期胆道癌患者的随机 II 期试验,比较纳武利尤单抗、吉西他滨和顺铂或纳武利尤单抗联合伊匹木单抗的疗效:BilT-01

Sahai, Vaibhav; Griffith, Kent A; Beg, Muhammad S; Shaib, Walid L; Mahalingam, Devalingam; Zhen, David B; Deming, Dustin A; Zalupski, Mark M

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer

老年III期结肠癌患者辅助化疗的生存结果

Khalil, Lana; Gao, Xingyu; Switchenko, Jeffrey M; Alese, Olatunji B; Akce, Mehmet; Wu, Christina; Diab, Maria; El-Rayes, Bassel F; Shaib, Walid L

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials

胆管癌患者治疗试验中性别相关的疗效差异

Ledenko, Matthew; Antwi, Samuel O; Arima, Shiho; Driscoll, Julia; Furuse, Junji; Klümpen, Heinz-Josef; Larsen, Finn Ole; Lau, David K; Maderer, Annett; Markussen, Alice; Moehler, Markus; Nooijen, Lynn E; Shaib, Walid L; Tebbutt, Niall C; André, Thierry; Ueno, Makoto; Woodford, Rachel; Yoo, Changhoon; Zalupski, Mark M; Patel, Tushar

Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study

局部治疗在转移性肛门鳞状细胞癌患者管理中的作用:一项基于国家癌症数据库的研究

Atallah, Rami P; Zhang, Yining; Zakka, Katerina; Jiang, Renjian; Huang, Zhonglu; Shaib, Walid L; Diab, Maria; Akce, Mehmet; Wu, Christina; El-Rayes, Bassel F; Alese, Olatunji B

Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies

DSP-7888 给药乳剂治疗晚期恶性肿瘤患者的多中心、开放标签、I期研究

Spira, Alexander; Hansen, Aaron R; Harb, Wael A; Curtis, Kelly K; Koga-Yamakawa, Erina; Origuchi, Makoto; Li, Zhonggai; Ertik, Bella; Shaib, Walid L

Evaluating the impact of the Patient Preference Assessment Tool on clinicians' recommendations for phase I oncology clinical trials

评估患者偏好评估工具对临床医生推荐 I 期肿瘤临床试验的影响

Hianik, Rachel S; Owonikoko, Taofeek; Switchenko, Jeffrey; Dixon, Margie D; Shaib, Walid L; Pentz, Rebecca D

Impact of Tumor Side on Clinical Outcomes in Stage II and III Colon Cancer With Known Microsatellite Instability Status

肿瘤侧别对已知微卫星不稳定性状态的II期和III期结肠癌临床结局的影响

Akce, Mehmet; Zakka, Katerina; Jiang, Renjian; Williamson, Shayla; Alese, Olatunji B; Shaib, Walid L; Wu, Christina; Behera, Madhusmita; El-Rayes, Bassel F

Role of Resection of the Primary in Metastatic Well-Differentiated Neuroendocrine Tumors

原发灶切除术在转移性高分化神经内分泌肿瘤治疗中的作用

Shaib, Walid L; Zakka, Katerina; Penley, McKenna; Jiang, Renjian; Akce, Mehmet; Wu, Christina; Maithel, Shishir K; Sarmiento, Juan M; Kooby, David; Behera, Madhusmita; Alese, Olatunji B; El-Rayes, Bassel F